(Q24656333)

English

Levetiracetam in the treatment of epilepsy

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

0 references

Levetiracetam in the treatment of epilepsy (English)

0 references

1 reference

based on heuristic

inferred from title

author name string

Bassel Abou-Khalil

1

0 references

language of work or name

0 references

publication date

June 2008

0 references

Neuropsychiatric Disease and Treatment

0 references

4

0 references

3

0 references

507-23

0 references

The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

7 April 2017

Selective blockade of N-type calcium channels by levetiracetam

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

7 April 2017

A proposed diagnostic scheme for people with epileptic seizures and with epilepsy: report of the ILAE Task Force on Classification and Terminology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

7 April 2017

Early identification of refractory epilepsy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

7 April 2017

Proposal for revised clinical and electroencephalographic classification of epileptic seizures. From the Commission on Classification and Terminology of the International League Against Epilepsy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

7 April 2017

Proposal for revised classification of epilepsies and epileptic syndromes. Commission on Classification and Terminology of the International League Against Epilepsy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

7 April 2017

Neuropsychological and neurophysiologic effects of carbamazepine and levetiracetam

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

28 September 2017

Intravenous levetiracetam in the treatment of benzodiazepine refractory status epilepticus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

28 September 2017

Comparison and predictors of rash associated with 15 antiepileptic drugs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

28 September 2017

Retrospective analysis of the efficacy and tolerability of levetiracetam in patients with metastatic brain tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

28 September 2017

Currently available antiepileptic drugs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

28 September 2017

Experimental and clinical evidence for loss of effect (tolerance) during prolonged treatment with antiepileptic drugs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

28 September 2017

Comparison of the efficacy and tolerability of new antiepileptic drugs: what can we learn from long-term studies?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

28 September 2017

Levetiracetam therapy in patients with brain tumour and epilepsy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

28 September 2017

Retrospective analysis of the efficacy and tolerability of levetiracetam in brain tumor patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

28 September 2017

The long term retention of levetiracetam in a large cohort of patients with epilepsy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

28 September 2017

Meta-analysis and indirect comparisons of levetiracetam with other second-generation antiepileptic drugs in partial epilepsy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

28 September 2017

Clinical pharmacokinetics of levetiracetam

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

28 September 2017

Efficacy and tolerability of the new antiepileptic drugs II: treatment of refractory epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the [...]

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

28 September 2017

Levetiracetam and partial seizure subtypes: pooled data from three randomized, placebo-controlled trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

28 September 2017

Long-term outcome of nonsurgical candidates with medically refractory localization-related epilepsy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

28 September 2017

Long-term experience with levetiracetam

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

28 September 2017

Clinically important drug interactions in epilepsy: interactions between antiepileptic drugs and other drugs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

28 September 2017

The pharmacokinetic characteristics of levetiracetam

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

28 September 2017

A systematic review of the behavioral effects of levetiracetam in adults with epilepsy, cognitive disorders, or an anxiety disorder during clinical trials.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

28 September 2017

Juvenile myoclonic epilepsy: under-appreciated and under-diagnosed

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

28 September 2017

Effects of antiepileptic comedication on levetiracetam pharmacokinetics: a pooled analysis of data from randomized adjunctive therapy trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

28 September 2017

Levetiracetam may be more effective for late-onset partial epilepsy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

28 September 2017

The anti-epileptic drug levetiracetam reverses the inhibition by negative allosteric modulators of neuronal GABA- and glycine-gated currents

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

28 September 2017

A systematic review of the safety profile of levetiracetam: a new antiepileptic drug.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

28 September 2017

Use of levetiracetam in special populations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

28 September 2017

Pharmacokinetics of levetiracetam

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

28 September 2017

Levetiracetam, oxcarbazepine, remacemide and zonisamide for drug resistant localization-related epilepsy: a systematic review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

28 September 2017

Suppression of post-hypoxic and post-encephalitic myoclonus with levetiracetam

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

28 September 2017

Pharmacokinetic profile of levetiracetam: toward ideal characteristics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

28 September 2017

Benign epilepsy of childhood with centrotemporal spikes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

28 September 2017

Levetiracetam use in critically ill patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

30 May 2018

Termination of complex partial status epilepticus by intravenous levetiracetam

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

30 May 2018

Levetiracetam or oxcarbazepine as monotherapy in newly diagnosed benign epilepsy of childhood with centrotemporal spikes (BECTS): an open-label, parallel group trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

30 May 2018

Antimyoclonic effect of levetiracetam in MERRF syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

30 May 2018

Use of levetiracetam in treating epilepsy associated with other medical conditions.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

30 May 2018

Levetiracetam in porphyric status epilepticus: a case report

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

30 May 2018

Levetiracetam as add-on therapy in generalised epilepsies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

30 May 2018

Levetiracetam in progressive myoclonic epilepsy: an exploratory study in 9 patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

30 May 2018

Adjunctive therapy versus alternative monotherapy in patients with partial epilepsy failing on a single drug: a multicentre, randomised, pragmatic controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

30 May 2018

Use of levetiracetam in a population of patients aged 65 years and older: a subset analysis of the KEEPER trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

30 May 2018

Discontinuation of levetiracetam because of behavioral side effects: a case-control study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

30 May 2018

Acute psychosis associated with levetiracetam

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

30 May 2018

The KEEPER trial: levetiracetam adjunctive treatment of partial-onset seizures in an open-label community-based study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

30 May 2018

Efficacy and tolerability of levetiracetam during 1-year follow-up in patients with refractory epilepsy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

30 May 2018

A paradoxical effect of levetiracetam may be seen in both children and adults with refractory epilepsy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

30 May 2018

Levetiracetam in refractory pediatric epilepsy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

30 May 2018

Development of tolerance during chronic treatment of kindled rats with the novel antiepileptic drug levetiracetam

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

30 May 2018

Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

30 May 2018

Profile of ucb L059, a novel anticonvulsant drug, in models of partial and generalized epilepsy in mice and rats

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

30 May 2018

Absence of pharmacokinetic drug interaction of levetiracetam with phenytoin in patients with epilepsy determined by new technique.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

19 June 2018

Intravenous levetiracetam: treatment experience with the first 50 critically ill patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

28 November 2018

Levetiracetam for the treatment of idiopathic generalized epilepsy with myoclonic seizures

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

28 November 2018

Intravenous levetiracetam in children with epilepsy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

28 November 2018

SV2A protein is a broad-spectrum anticonvulsant target: functional correlation between protein binding and seizure protection in models of both partial and generalized epilepsy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

28 November 2018

The use of levetiracetam in a child with nonconvulsive status epilepticus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

28 November 2018

Intravenous levetiracetam terminates refractory focal status epilepticus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

28 November 2018

Serum concentration/dose ratio of levetiracetam before, during and after pregnancy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

28 November 2018

Effects of levetiracetam as an add-on therapy on cognitive function and quality of life in patients with refractory partial seizures

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

28 November 2018

Therapeutic drug monitoring of levetiracetam by high-performance liquid chromatography with photodiode array ultraviolet detection: preliminary observations on correlation between plasma concentration and clinical response in patients with refractor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

28 November 2018

Are psychiatric adverse events of antiepileptic drugs a unique entity? A study on topiramate and levetiracetam

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

28 November 2018

Levetiracetam monotherapy in juvenile myoclonic epilepsy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

28 November 2018

Levetiracetam in nonconvulsive status epilepticus in childhood: a case report.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

28 November 2018

Placebo-controlled study of levetiracetam in idiopathic generalized epilepsy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

28 November 2018

Prolonged exposure to levetiracetam reveals a presynaptic effect on neurotransmission

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

28 November 2018

The influence of antiepileptic drugs on cognition: a comparison of levetiracetam with topiramate.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

28 November 2018

Levetiracetam in three cases of progressive myoclonus epilepsy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

28 November 2018

Levetiracetam monotherapy for children and adolescents with benign rolandic seizures.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

28 November 2018

Levetiracetam as a treatment option in non-convulsive status epilepticus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

28 November 2018

Levetiracetam in pregnancy: preliminary experience from the UK Epilepsy and Pregnancy Register

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

28 November 2018

Single-dose bioavailability of levetiracetam intravenous infusion relative to oral tablets and multiple-dose pharmacokinetics and tolerability of levetiracetam intravenous infusion compared with placebo in healthy subjects

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

28 November 2018

Levetiracetam in a broad population of patients with refractory epilepsy: interim results of the international SKATE trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

28 November 2018

Onset of action of levetiracetam: a RCT trial using therapeutic intensive seizure analysis (TISA).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

28 November 2018

Determinants of success in the use of oral levetiracetam in status epilepticus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

28 November 2018

The use of levetiracetam in refractory status epilepticus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

28 November 2018

Levetiracetam in patients with generalised epilepsy and myoclonic seizures: an open label study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

28 November 2018

Efficacy and safety of levetiracetam (up to 2000 mg/day) in Taiwanese patients with refractory partial seizures: a multicenter, randomized, double-blind, placebo-controlled study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

28 November 2018

Levetiracetam efficacy in epileptic syndromes with continuous spikes and waves during slow sleep: experience in 12 cases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

28 November 2018

Levetiracetam in patients with refractory epilepsy: results of the SKATE trial in Austria, Germany and Switzerland

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

28 November 2018

Clinical experience with levetiracetam in idiopathic generalized epilepsy according to different syndrome subtypes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

28 November 2018

Levetiracetam in the treatment of status epilepticus in adults: a study of 13 episodes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

28 November 2018

Levetiracetam in patients with cortical myoclonus: a clinical and electrophysiological study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

28 November 2018

Fast and sustained efficacy of levetiracetam during titration and the first 3 months of treatment in refractory epilepsy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

28 November 2018

Failed surgery for temporal lobe epilepsy: predictors of long-term seizure-free course

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

28 November 2018

Nonconvulsive status epilepticus on treatment with levetiracetam

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

28 November 2018

Levetiracetam concentrations in serum and in breast milk at birth and during lactation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

28 November 2018

Levetiracetam use and pregnancy outcome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

28 November 2018

Levetiracetam for seizures after liver transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

28 November 2018

Limited efficacy of levetiracetam on myoclonus of different etiologies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

28 November 2018

Levetiracetam in the treatment of infantile spasms

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

28 November 2018

Rapid onset of action of levetiracetam in refractory epilepsy patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

28 November 2018

A prospective analysis of the outcome of levetiracetam in clinical practice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

28 November 2018

Efficacy of levetiracetam in pharmacoresistant continuous spikes and waves during slow sleep

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

28 November 2018

Antimyoclonic effect of levetiracetam in 13 patients with Unverricht-Lundborg disease: clinical observations.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

28 November 2018

Levetiracetam during 1-year follow-up in children, adolescents, and young adults with refractory epilepsy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

28 November 2018

Levetiracetam in adult patients with and without learning disability: focus on behavioral adverse effects

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

28 November 2018

Levetiracetam in the treatment of Lennox-Gastaut syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

28 November 2018

Psychiatric adverse events in patients with epilepsy and learning disabilities taking levetiracetam

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

28 November 2018

Bioptically demonstrated Lafora disease without EPM2A mutation: a clinical and neurophysiological study of two sisters

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

28 November 2018

Serum concentrations of Levetiracetam in epileptic patients: the influence of dose and co-medication

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

28 November 2018

Levetiracetam treatment of idiopathic generalised epilepsy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

28 November 2018

Levetiracetam: preliminary experience in patients with primary brain tumours

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

28 November 2018

Landau–Kleffner syndrome responsive to levetiracetam

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

28 November 2018

Seizure‐free Days Observed in Randomized Placebo‐controlled Add‐on Trials with Levetiracetam in Partial Epilepsy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

28 November 2018

Psychiatric adverse events during levetiracetam therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

28 November 2018

Evolving antiepileptic drug treatment in juvenile myoclonic epilepsy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

28 November 2018

Levetiracetam monotherapy during pregnancy: a case series

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

28 November 2018

Levetiracetam monotherapy for liver transplant patients with seizures

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

28 November 2018

Effect of levetiracetam in refractory childhood epilepsy syndromes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

28 November 2018

Efficacy of levetiracetam in a patient with Unverricht-Lundborg progressive myoclonic epilepsy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

28 November 2018

Maintenance of improvement in health-related quality of life during long-term treatment with levetiracetam

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

28 November 2018

Dramatic effect of levetiracetam on epileptic negative myoclonus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

28 November 2018

Levetiracetam for benign epilepsy of childhood with centrotemporal spikes-three cases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

28 November 2018

An open-label study of levetiracetam at individualised doses between 1000 and 3000 mg day(-1) in adult patients with refractory epilepsy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

28 November 2018

Clinical experience of marketed Levetiracetam in an epilepsy clinic-a one year follow up study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

28 November 2018

Levetiracetam control of myoclonus in a patient with Creutzfeldt-Jakob disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

28 November 2018

Evidence for sustained efficacy of levetiracetam as add-on epilepsy therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

28 November 2018

Levetiracetam efficacy in refractory partial-onset seizures, especially after failed epilepsy surgery

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

28 November 2018

Levetiracetam, a new antiepileptic agent: lack of in vitro and in vivo pharmacokinetic interaction with valproic acid

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

28 November 2018

Amelioration of spinal myoclonus with levetiracetam

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

28 November 2018

Levetiracetam does not alter the pharmacokinetics of an oral contraceptive in healthy women

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

28 November 2018

Efficacy and safety of levetiracetam in children with partial seizures: an open-label trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

28 November 2018

Suppression of cortical myoclonus by levetiracetam

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

28 November 2018

Levetiracetam psychosis in children with epilepsy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

28 November 2018

Pharmacokinetic study of levetiracetam in children

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

28 November 2018

Lack of effect of repeated administration of levetiracetam on the pharmacodynamic and pharmacokinetic profiles of warfarin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

28 November 2018

A pilot tolerability and efficacy study of levetiracetam in patients with chronic myoclonus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

28 November 2018

Repeated administration of the novel antiepileptic agent levetiracetam does not alter digoxin pharmacokinetics and pharmacodynamics in healthy volunteers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

28 November 2018

Long-term continuation of levetiracetam in patients with refractory epilepsy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

28 November 2018

Levetiracetam inhibits the high-voltage-activated Ca(2+) current in pyramidal neurones of rat hippocampal slices

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

28 November 2018

Effect of levetiracetam on epilepsy-related quality of life. N132 Study Group.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

28 November 2018

A multicentre, double-blind, randomized, parallel group study to evaluate the tolerability and efficacy of two oral doses of levetiracetam, 2000 mg daily and 4000 mg daily, without titration in patients with refractory epilepsy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2526377

28 November 2018

In vitro evaluation of potential drug interactions with levetiracetam, a new antiepileptic agent

1 reference

https://pubmed.ncbi.nlm.nih.gov/18830435

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Levetiracetam intravenous infusion: a randomized, placebo-controlled safety and pharmacokinetic study

1 reference

https://pubmed.ncbi.nlm.nih.gov/18830435

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Double-blind placebo-controlled trial of adjunctive levetiracetam in pediatric partial seizures

1 reference

https://pubmed.ncbi.nlm.nih.gov/18830435

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

IV levetiracetam in the management of non-convulsive status epilepticus

1 reference

https://pubmed.ncbi.nlm.nih.gov/18830435

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epilepsy after the first drug fails: substitution or add-on?

1 reference

https://pubmed.ncbi.nlm.nih.gov/18830435

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and safety of levetiracetam in clinical practice: results of the SKATE trial from Belgium and The Netherlands

1 reference

https://pubmed.ncbi.nlm.nih.gov/18830435

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Levetiracetam intravenous infusion as an alternative to oral dosing in patients with partial-onset seizures

1 reference

https://pubmed.ncbi.nlm.nih.gov/18830435

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of levetiracetam and controlled-release carbamazepine in newly diagnosed epilepsy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18830435

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in patients with refractory partial seizures. European Levetiracetam Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/18830435

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An open-label trial of levetiracetam in severe myoclonic epilepsy of infancy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18830435

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Photosensitive epilepsy: a model to study the effects of antiepileptic drugs. Evaluation of the piracetam analogue, levetiracetam

1 reference

https://pubmed.ncbi.nlm.nih.gov/18830435

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Open label, long-term, pragmatic study on levetiracetam in the treatment of juvenile myoclonic epilepsy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18830435

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of levetiracetam in hospitalized patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/18830435

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and tolerability of levetiracetam 3000 mg/d in patients with refractory partial seizures: a multicenter, double-blind, responder-selected study evaluating monotherapy. European Levetiracetam Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/18830435

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of levetiracetam in infants and young children with epilepsy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18830435

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Suppression of post-hypoxic and post-encephalitic myoclonus with levetiracetam

1 reference

https://pubmed.ncbi.nlm.nih.gov/18830435

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Levetiracetam for partial seizures: results of a double-blind, randomized clinical trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/18830435

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term levetiracetam treatment of epilepsy patients: clinical audit

1 reference

https://pubmed.ncbi.nlm.nih.gov/18830435

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of levetiracetam during pregnancy, delivery, in the neonatal period, and lactation

1 reference

https://pubmed.ncbi.nlm.nih.gov/18830435

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of age and comedication on levetiracetam pharmacokinetics and tolerability

1 reference

https://pubmed.ncbi.nlm.nih.gov/18830435

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Levetiracetam pharmacokinetics in neonates at birth

1 reference

https://pubmed.ncbi.nlm.nih.gov/18830435

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predicting drug-resistant patients who respond to add-on therapy with levetiracetam

1 reference

https://pubmed.ncbi.nlm.nih.gov/18830435

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2147/NDT.S2937

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

PMC publication ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

PubMed publication ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q24656333&oldid=1518284229"